Profile data is unavailable for this security.
About the company
Sino Medical Sciences Technology Inc is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary drug stent system and balloon dilatation catheters. The Company manufactures and sells products covering two main categories: coronary intervention and neurointervention, including coronary stents, coronary balloons, neurostents, neuroballoons, and related products. These products are primarily used in interventional medical treatments such as coronary artery stenting. The Company conducts its business within the domestic market and overseas markets.
- Revenue in CNY (TTM)504.11m
- Net income in CNY29.36m
- Incorporated2007
- Employees691.00
- LocationSino Medical Sciences Technology Inc3F, Area A,TEDA Biomedical R&D Mansion, No. 5 FourTIANJIN 300457ChinaCHN
- Phone+86 1 082163261
- Fax+86 1 082162787
- Websitehttps://www.sinomed.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOB Biotech Group Corp Ltd | 387.48m | 36.43m | 9.04bn | 529.00 | 243.99 | 10.77 | -- | 23.34 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Shinva Medical Instrument Co Ltd | 9.58bn | 508.92m | 9.37bn | 8.14k | 18.46 | 1.20 | -- | 0.9788 | 0.837 | 0.837 | 15.78 | 12.91 | 0.6286 | 2.20 | 4.50 | 1,177,051.00 | 3.30 | 4.12 | 6.27 | 8.97 | 24.46 | 25.09 | 5.24 | 5.61 | 0.8863 | -- | 0.124 | 21.15 | 0.0874 | 2.71 | 5.75 | -4.29 | 14.30 | 26.58 |
| Sino Medical Sciences Technology Inc | 504.11m | 29.36m | 9.39bn | 691.00 | 318.36 | 10.38 | -- | 18.63 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.52bn | 384.21m | 10.01bn | 2.16k | 28.54 | 1.92 | -- | 3.97 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| Shanghai Runda Medical Technology Co Ltd | 7.40bn | -157.84m | 10.04bn | 3.14k | -- | 2.40 | -- | 1.36 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.26bn | 255.88m | 10.39bn | 2.81k | 40.30 | 2.41 | -- | 4.59 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Xiangyu Medical Co Ltd | 773.93m | 73.51m | 10.88bn | 2.34k | 142.00 | 5.37 | -- | 14.06 | 0.4789 | 0.4789 | 5.07 | 12.67 | 0.2548 | 1.01 | 11.40 | 330,597.70 | 2.35 | 8.54 | 3.26 | 10.17 | 65.98 | 66.78 | 9.22 | 28.37 | 0.9871 | -- | 0.2387 | 32.49 | -0.1717 | 11.71 | -54.68 | -4.41 | 83.55 | -- |
Data as of Feb 11 2026. Currency figures normalised to Sino Medical Sciences Technology Inc's reporting currency: Chinese Yuan Renminbi CNY
4.72%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Orient Securities Asset Management Co. Ltd.as of 30 Jun 2025 | 7.36m | 2.56% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 1.86m | 0.65% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2025 | 1.50m | 0.52% |
| Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025 | 895.29k | 0.31% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 434.46k | 0.15% |
| Huaxi Fund Management Co. Ltd.as of 30 Jun 2025 | 363.66k | 0.13% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 343.39k | 0.12% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 327.28k | 0.11% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 278.93k | 0.10% |
| CIB Fund Management Co., Ltd.as of 30 Jun 2025 | 195.60k | 0.07% |
More ▼
Data from 30 Jun 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
